Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The package arrived on a two-day delivery timeline after the prescription was processed
doi: 10.1002/ptr.7791 100
Nausea Vomiting Diarrhea Constipation Decreased appetite Injection-site reactions Gallbladder events (cholelithiasis, cholecystitis) reported in some Phase 2 participants Increased heart rate Possible pancreatitis (per GLP-1 class data not specifically reported in retatrutide trials) Frequently asked questions Is retatrutide FDA-approved
Hypersensitivity Reaction to Tirzepatide With Demonstrated Tolerance to Semaglutide: A [PMID: 42487660] Laboratory literature summary: Hypersensitivity Reaction to Tirzepatide With Demonstrated Tolerance to Semaglutide: A Case Report
US$ 22.61
US$ 24.08
US$ 22.68
US$ 29.87
US$ 21.35
US$ 29.13
US$ 27.23
US$ 26.03
